Article Text

Download PDFPDF

British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism
  1. Luke S Howard1,
  2. Steven Barden2,
  3. Robin Condliffe3,
  4. Vincent Connolly4,
  5. Chris Davies5,
  6. James Donaldson6,
  7. Bernard Everett7,
  8. Catherine Free8,
  9. Daniel Horner9,10,
  10. Laura Hunter11,
  11. Jasvinder Kaler12,
  12. Catherine Nelson-Piercy13,
  13. Emma O’Dowd14,
  14. Raj Patel15,
  15. Wendy Preston8,
  16. Karen Sheares16 and
  17. Campbell Tait17
  1. 1 National Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK
  2. 2 Royal Sussex County Hospital, Brighton, UK
  3. 3 Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
  4. 4 South Tees Hospitals NHS Trust, Middlesbrough, UK
  5. 5 Royal Berkshire Hospital, Reading, UK
  6. 6 Derby Teaching Hospitals NHS Foundation Trust, Derby, UK
  7. 7 Chesterfield, UK
  8. 8 Department of Respiratory Medicine, George Eliot Hospital NHS Trust, Nuneaton, UK
  9. 9 Emergency Department, Salford Royal NHS Foundation Trust, Salford, UK
  10. 10 The Royal College of Emergency Medicine, London, UK
  11. 11 St Thomas’ Hospital, London, UK
  12. 12 Cardiovascular Department, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
  13. 13 Women’s Health Academic Centre, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
  14. 14 Department of Respiratory Medicine, Nottingham City Hospital, Nottingham, UK
  15. 15 King’s College Hospital NHS Foundation Trust, London, UK
  16. 16 Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK
  17. 17 Department of Haematology, Glasgow Royal Infirmary, Glasgow, Scotland
  1. Correspondence to Dr Luke S Howard; l.howard{at}


The following is a summary of the recommendations and good practice points for the BTS Guideline for the initial outpatient management of pulmonary embolism. Please refer to the full guideline for full information about each section.

  • pulmonary embolism

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:

Statistics from


  • Contributors LSH chaired the guideline group, and as lead author led the drafting and revision of the document. All authors drafted sections of the guideline and undertook revisions of the paper. LSH had final responsibility for the guideline.

  • Competing interests RC received funding from BTG, Actelion and MSD; BE received funding from Astra Zeneca and Diageo; DH received finding from Creavotech; LSH received funding from GSK, Endotronix, Actelion, Bayer, MSD, BTG and BMS; RP received funding from Bayer and Daiichi Sankyo; KS received funding from Actelion; CT received funding from Bayer, Daiichi Sankyo and Novo Nordisk; CNP received funding from UCB and Alliance; WP received funding from ARNS, AZ and BI.

  • Provenance and peer review Commissioned; internally peer reviewed.

  • Data sharing statement No additional data are available.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.